Bill Snyder Archive — Page 18 of 121

3D rendering of an enterovirus D68 particle covered by red, yellow, and blue viral proteins and orange and purple antibodies, overlaid on a colorized electron micrograph showing green virus particles.
June 28, 2024

Antibody trial launched to address enterovirus threat

Enterovirus D68 has caused an increasing number of infections during the past decade and is associated with acute flaccid myelitis, a polio-like condition that mostly affects children and causes sudden weakness and paralysis.

Two men stand side by side in a bright indoor hallway, smiling at the camera. The man on the left wears a white button-down shirt, and the man on the right wears a plaid button-down shirt.
June 25, 2024

Gene variant may underlie diabetes disparities: study

The study was the largest ancestry-stratified, genetic estimation of the heritability of diabetic retinopathy conducted to date and included an unprecedented number of individuals of non-Hispanic African ancestry — more than 46,000.

Registered respiratory therapist Natasha Vanderbilt, RRT, encourages 10-year-old Kate to exhale a complete breath during a lung function test in the Pediatric Pulmonary Medicine clinic. (photo by Susan Urmy)
June 14, 2024

Removing race improves accuracy of lung function testing in children

The study suggests the adjustment for race in spirometry resulted in an underreporting — and thus possibly undertreatment — of chronic lung diseases, including asthma and cystic fibrosis, in Black children.

Illustration of a spherical parainfluenza virus particle with a textured orange surface and numerous irregular multicolored spike-like structures, alongside a blurred particle in the foreground.
June 12, 2024

Scientists find antibodies that block parainfluenza virus infection

The antibodies may have clinical benefit as antiviral drugs to treat potentially life-threatening infections in elderly and immunosuppressed patients.

Brooke Emerling, PhD, and Raymond Blind, PhD (seated, in foreground) at a 2023 scientific symposium they organized. Standing next to Blind is Hua Ya, PhD, from the City of Hope Comprehensive Cancer Center. Behind him in the light blue shirt is Emilio Hirsch, PhD, from the University of Torino, Italy.
June 7, 2024

Discovery raises hopes for new cancer therapy

The study connected the Hippo signaling pathway to phosphoinositides, a particular type of lipid, or fat molecule, which regulates cell functions that are critical in cancer, obesity and diabetes.

Graduate student Taralynn Mack, left, pipettes a sample while Alexander Bick, MD, graduate student Hannah Poisner, and Celestine Wanjalla, MD, PhD, look on.
June 4, 2024

Research raises hope for treating potentially lethal blood condition

Roughly 1 in 10 people over age 70 will develop CHIP, an explosive, clonal growth of abnormal blood cells that increases risk of blood cancers and death from cardiovascular, lung and liver disease.